International Journal of Virology and Molecular Biology
p-ISSN: 2163-2219 e-ISSN: 2163-2227
2016; 5(2): 27-33
doi:10.5923/j.ijvmb.20160502.01
Iram Amin1, Shagufta Naz2, Muhammad Shahid1, Samia Afzal1, Usman Ashraf1, Asif Rasheed1, Afza Rasul2, Rabia Nawaz1, Sadia Zahid1, Iqra Almas1, Khadija Zahid1, Farkhanda Manzoor2, Muhammad Idrees3
1Division of Molecular Virology, National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan
2Lahore College for Women University, Lahore, Pakistan
3Hazara University, Mansehra, Pakistan
Correspondence to: Iram Amin, Division of Molecular Virology, National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Email: | ![]() |
Copyright © 2016 Scientific & Academic Publishing. All Rights Reserved.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Hepatitis C virus (HCV) is estimated to infect nearly 200 million individuals globally, including approximately 10 million in Pakistan. The newly approved antiviral medicines belonging to Direct Antiviral Agents (DAA) compounds are very expensive and their access is difficult for poor patients. There is a need to develop the more effective, cheap and less toxic antiviral drugs that can be used along with standard PEG-IFNα and Ribavirin therapy that is still in use in developing countries. In this invitrostudy, we examined the inhibitory effect of Thiazolide derivatives (RM4832 and RM4863) against hepatitis C virus in Huh-7 cell lines. The RNA quantitative results showed a sharp significant antiviral response shown by both of the compounds by decreasing the viral titers after 24 hours of incubation. Compounds showed improved antiviral activity at the dose of 2.0ul (400uM concentration) and 2.5ul (500uM concentration) respectively. This study provides the basis for future work on these compounds especially to determine the specific pathway and mechanism for inhibitory action in the replicon systems of viral hepatitis. Thiazolide derivatives show promising inhibitory effects against HCV genotypes 3a infection, which suggests its possible use as complementary and alternative medicine for HCV viral infection.
Keywords: HCV, Genotypes, Huh-7 cell line, Thiazolides
Cite this paper: Iram Amin, Shagufta Naz, Muhammad Shahid, Samia Afzal, Usman Ashraf, Asif Rasheed, Afza Rasul, Rabia Nawaz, Sadia Zahid, Iqra Almas, Khadija Zahid, Farkhanda Manzoor, Muhammad Idrees, Inhibitory Effects of Thiazolide Compounds against Hepatitis C virus: in vitro Study, International Journal of Virology and Molecular Biology, Vol. 5 No. 2, 2016, pp. 27-33. doi: 10.5923/j.ijvmb.20160502.01.
![]() | Figure 1. Toxicity analysis of different concentrations of compound-A in Huh-7 cells |
![]() | Figure 2. Toxicity analysis of different concentrations of compound-B in Huh-7 cells |
![]() | Figure 3. Antiviral activity of Thiazolide derivatives A & B at 2.0ul and 2.5ul in Male patients |
![]() | Figure 4. Antiviral activity of Thiazolide derivatives A & B at 2.0ul and 2.5ul in Female patients |